MDNU Medical Nutrition Usa (MM)

Medical Nutrition USA, Inc. (NASDAQ: MDNU), a developer and distributor of proprietary, nutrition medicine products, announced today that Murphy Analytics, an equity research group, initiated coverage and issued its first report on the company.

The report outlines the company's growth and analyzes recent financial performance.

Highlights:

--  "Since being introduced to the institutional market less than six
    years ago, over 50 million servings of Pro-Stat� have been administered
    in over 5,000 US health care facilities."

--  "The US population aged 65 and over is likely to double over the next
    two decades.  MDNU is positioned to benefit from this massive demographic
    shift by leveraging its competitive position to further penetrate this
    population with new products while simultaneously expanding its target
    market to include institutional and, beginning in the second half of
    calendar 2009, retail users."

--  "With a strong market position for the existing product offering, an
    attractive opportunity for expansion into retail, and the ability to
    leverage the existing distributor network into the Canadian institutional
    market, MDNU is well positioned for growth in revenue and profitability.
    Additionally, the Company's very strong balance sheet provides the
    capitalization to execute these expansion plans and to consider
    complementary acquisitions."
    

"This report provides insights into our company's performance and prospects that should be helpful to the investment community," Frank A. Newman, Medical Nutrition USA's Chairman, and Chief Executive Officer, said. "We are pleased that Murphy Analytics has initiated coverage and think that analyst coverage will help increase awareness of what our company has achieved and what we can accomplish in the months and years ahead."

The report can be accessed in the Investor Relations section of the Medical Nutrition web site: www.mdnu.com.

About Medical Nutrition USA Inc.

Medical Nutrition USA develops and distributes products for the nutritionally at risk who are under medical supervision. Its products are used primarily in long-term care facilities, hospitals, dialysis clinics and bariatric clinics. The Company's product lines include Pro-Stat�, Fiber-Stat�, and UTI-Stat(TM), as well as private label products.

This press release contains forward-looking statements that are subject to certain risks and uncertainties. Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed. Risks and uncertainties that could cause or contribute to such material difference include, but are not limited to, general economic conditions, changes in customer demand, changes in trends in the nursing home, renal care, health food and bariatric surgery markets, changes in competitive pricing for products, and the impact of our competitors' new product introductions. Our future financial condition and results of operations, as well as any forward-looking statements are subject to change and inherent risk and uncertainties. Other important factors that may cause actual results to differ materially from those expressed in forward-looking statements is contained in the Medical Nutrition USA, Inc. Annual Report on Form 10-K for the year ended January 31, 2008 as filed with the Securities and Exchange Commission on April 29, 2008 and Form 10-Q for the quarter ended Oct. 31, 2008 filed on Dec. 15, 2008.

Contacts: Medical Nutrition USA, Inc. Frank J. Kimmerling Vice President/CFO 800.221.0308 Email Contact Investor Relations Adam Friedman 212.981.2529 x18 Email Contact